Zydus seeks nod for world s first plasmid DNA Covid vax | India News indiatimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiatimes.com Daily Mail and Mail on Sunday newspapers.
“We will have a good amount of data on children in this age group. If everything goes well in terms of safety, the vaccine will potentially be approved for use in children aged 12 to 18 years,” said Dr Sharvil Patel, managing director, Cadila Healthcare Limited
AHMEDABAD: After covering adults and children aged between12 and18 years under the ongoing clinical trials of its Covid-19 vaccine ZyKov-D, Zydus Cadila now plans to test its plasmid DNA vaccine for children in the age group of 5 to 12 years.
The pharma major has already covered 800-plus children in 12-18 years clinical trials. “We will have a good amount of data on children in this age group. If everything goes well in terms of safety, the vaccine will potentially be approved for use in children aged 12 to 18 years,” said Dr Sharvil Patel, managing director, Cadila Healthcare Limited, the flagship company of the Ahmedabad-based Zydus Cadila Group.
States may hit a roadblock in global sourcing quest - The Hindu BusinessLine thehindubusinessline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindubusinessline.com Daily Mail and Mail on Sunday newspapers.
Multiples, CPPIB and Jhunjhunwala’s RARE to buy Cadila’s Animal Health biz for Rs 2921 crores
SECTIONS
Multiples, CPPIB and Jhunjhunwala’s RARE to buy Cadila’s Animal Health biz for Rs 2921 croresET Bureau
Last Updated: May 12, 2021, 12:06 PM IST
Share
Synopsis
The consortium, through an SPV controlled by them, has signed a definitive agreement to acquire Animal Healthcare Established Markets Undertaking focused on India and certain other countries, the company said in a statement.
Zydus AH is the second largest and one of the fastest growing animal health businesses in India.
The consortium, through an SPV controlled by them, has signed a definitive agreement to acquire Animal Healthcare Established Markets Undertaking focused on India and certain other countries, the company said in a statement.